What is the market doing?
What the tape says about ZBIO
Zenas BioPharma, Inc. is +123% over the past year while the S&P 500 is +23%: 101 points ahead of the market.
+123%
1-year return · S&P 500 +23%
- vs 200-day average
- +27%
vs 200-day average · a clear uptrend
- RSI (14)
- 54
RSI (14) · neutral
- Below its 52-week high
- −23%
Below its 52-week high
Details›
- Last close2026-08-26
- $33.06
- 1 monthS&P 500 +3.7%
- +6.6%
- 1 yearS&P 500 +23%
- +123%
- vs 50-day average$26.48
- +25%
- 52-week high
- $43.17
- 52-week low
- $14.63
- Annualised volatility
- 106%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $11M
| Year | Return |
|---|---|
| 2026 (year to date) | −9.0% |
| 2025 | +343% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.